CJEU (C-179/16, Hoffman-La Roche): infringement of pharmacovigilance obligations may give rise to EU competition law liability

On 23 January 2018, the European Court of Justice (“CJEU”) issued its preliminary ruling in the Hoffman-La Roche case, where it had the chance to address some major issues regarding competition law in the pharmaceutical sector. The request for a preliminary ruling had been referred by the Italian Consiglio di Stato in relation to a cartel case where the Italian Competition Authority had fined Roche and Novartis for a total amount of 180 million euros.

Continue reading “CJEU (C-179/16, Hoffman-La Roche): infringement of pharmacovigilance obligations may give rise to EU competition law liability”

Latest update on the crispr cas9: the patent battle continues in Europe

Guest post by Lucia Tamayo Del Portillo*

After causing major buzz in 2017 due to the decision of the patent interference procedure before the United States Patent and Trademark Office (USPTO) which is currently under review in Federal Court, the Crispr Cas9 patent battle enters into 2018 with another shocking decision, this time rendered by the opposition division of the European Patent Office (EPO).

As readers may recall, Crispr Cas9 is a gene editing tool that allows scientists to manipulate DNA of living organisms in a cost-effective manner with accurate precision and the possibility to add, amend or delete parts of DNA sequences. The technology has multiple applications in different industries, with, of course, human health being the most promising and profitable one. Continue reading “Latest update on the crispr cas9: the patent battle continues in Europe”

Beijing IP Court delivers the first judgment on GUI design infringement in China

China’s first lawsuit for infringement of graphical user interface (GUI) design has been recently concluded by the Beijing IP Court. This case has attracted much public attention, as GUI designs have become protectable in China by so-called design patents only as of 1 May 2014, and despite a large number of GUI design patents being granted since then, their enforceability remained untested until the present case. The judgment issued on 25 December 2017 now results in heated discussion and leaves, in particular, software developers counting on strong GUI design protection very disappointed. Continue reading “Beijing IP Court delivers the first judgment on GUI design infringement in China”